Approval · Notice of Compliance 16111 · 2014
DUTASTERIDE CAPSULES: Notice of Compliance 16111
Issued September 17, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16111
- Date
- September 17, 2014
- Company
- Strides Arcolab Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Type i and ii alpha-reductase inhibitor
- Canadian reference product
- AVODART
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUTASTERIDE CAPSULES | 02427842 | Approved |
Medicinal ingredients
- DUTASTERIDE 0.5 MG per CAP